beat rais compani fire cylind
report anoth strong quarter momentum continu
 analyt ta segment return growth albeit modest
cc contract sale view quarter support posit
outlook compani convey investor day link believ
acceler growth trend persist drive ebitda ep growth
expand multipl
highlight quarter confer call
ta organ cc growth acceler oce world
evid see strong adopt new offer
 anoth strong book quarter includ pass
revenue exclud pass revenue core power
nextgen award top mil quarter
contract sale medic solut first posit growth quarter sinc
board continu commit repurchas share buy back
mil stock line
revenu ep guidanc rang rais out-performance ta
share buyback ebitda rang tighten intern invest earli
stage deploy near term margin headwind
point concern
investor want find someth pick guidanc came
consensu midpoint think time seen
street mis-model steep ramp prior year given overal rais
guidanc high visibl good execut see concern
estim chang take revenu ebitda estim
given out-performance quarter sustain
trend view ep beat ep
minor adjust add-back
pt price target unchang recal recent rais june
target assum stock trade new ep
estim in-line multipl similar growth size busi
strong demand oce rwe
come backlog growth
growth give visibl growth
tr target
revenu depict prior year
adjust account rule
revenu prior reflect account
page
share upsid current strh factsetstrh scenariovalu ia hold inc
page
sandi draper statement dollar y/i total gross depreci restructur merger impair oper fit incl restruc net interest expens incom incom incom tax tax equiti unconsolid equiti earn unconsolid net net loss incom attribut non-controlling net incom attribut dilut dilut share forma adjust net adj pre-tax tax non-gaap net non-gaap ep onward recast growth forma adjust ebitdaadjust ebitda onward recast margin robinson humphrey research estimatestick iqva
iqvia largest cro revenu oper countri employe
compani found headquart durham nc compani formerli quintil
merg im health combin entiti iqvia oper three segment commerci
solut data technolog drive real world evid use life sceinc client clinic
trial integr healthcar servic contract sale compris
respect sale iqvia first went public taken privat privat equiti
went public acquir im health
buy rate base view ebitda growth exceed revenu growth due
oper leverag cost synergi recognit expect manag reinforc oper
perform share repurchas expect contribut mid-teen ep growth
also think acquir im busi may benefit multipl expans mid-cap peer
technolog servic space given acquisit im
valuat risk
pt assign probabl low case price-to-earnings stock mid case
price-to-earnings stock high case price-to-earnings stock pt impli price-to-earnings
multipl ep estim ahead peer averag ntm multipl
justifi view given peer lead book perform anticip acceler revenu
growth one leader ep growth well view investor begin compar
mid/larg cap high visibl growth compani typic trade pe
low- mid-
risk rate price target
continu cancel late stage busi net book bill remain target
merger synergi fail materi custom attrit due im merger
sandi draper herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
